17 DEC 2020 Pharmaceuticals Formation of a Licensing Agreement Covering Japan and Europe for the Lupus Nephritis Drug "Voclosporin"
10 DEC 2020 Nutraceuticals Otsuka Pharmaceutical Signs On as "B. League Supporting Company" -To cooperate with physical conditioning and regional healthcare-related initiatives-
16 NOV 2020 Nutraceuticals UL·OS Medicated Scalp Shampoo and Medicated Skin Wash to Appear in New Packaging
30 OCT 2020 Pharmaceuticals Quick NaviTM Rapid Diagnostic Test in Japan Now Supports Simultaneous Testing for Influenza and COVID-19 Through Collection of a Single Testing Sample
15 OCT 2020 Nutraceuticals Debut of InnerSignal Skin Care Brand Outside Japan - Launched in South Korea as Functional Cosmetics with Two Key Benefits -
15 OCT 2020 Pharmaceuticals Otsuka and its subsidiary Astex announce results of phase 3, ASTRAL-2 and ASTRAL-3 trials of guadecitabine in patients with previously treated AML and MDS/CMML
12 OCT 2020 Pharmaceuticals Positive Top-Line Results in Phase 3 Trial of OPC-61815, a V2 -Receptor Antagonist for the Treatment of Cardiac Edema
5 OCT 2020 Pharmaceuticals Quick NaviTM-COVID 19 Ag Rapid Diagnostic Test in Japan Now Enables Test Sample Collection from Front of Nasal Cavity
30 SEP 2020 Corporate Otsuka Group Acquires ISO 14001 Certification -Reinforcement of group-wide environmental initiatives-
28 SEP 2020 Pharmaceuticals Otsuka Has Filed an Application in Japan for Approval of Difamilast (OPA-15406) as an Atopic Dermatitis Drug
25 SEP 2020 Pharmaceuticals Otsuka's ABILIFY MAINTENA approved for the additional indication of bipolar I disorder in Japan
18 SEP 2020 Nutraceuticals - Creating a Society that Supports Ongoing Employee Health - Full-scale launch of "Kenko Shacho" community website connecting corporate leaders
10 SEP 2020 Nutraceuticals Smart Nutrition for New Lifestyles Announcing SOYJOY Green Tea & Macadamia Moist Texture Highlights the Mellow Astringency and Savor of Green Tea
7 SEP 2020 Nutraceuticals Otsuka Pharmaceutical Supports High School Students in Summer 2020 Supporting events across Japan that are close to their hearts, including alternative athletic competitions
3 SEP 2020 Pharmaceuticals Top-line Results from Global Phase 3 Program of Vadadustat, a Drug Candidate for Treatment of Renal Anemia due to Chronic Kidney Disease in Non-Dialysis Patients
26 AUG 2020 Pharmaceuticals Novartis Pharma and Otsuka to Launch Entresto® Tablets in Japan for Patients with Chronic Heart Failure
11 AUG 2020 Pharmaceuticals Otsuka to Co-market New Diagnostic Test for COVID-19, Quick Navi-COVID 19 Ag-Confirmation of test results in just 15 minutes, and easy-to-read results shown in two contrasting colors-
29 JUL 2020 Pharmaceuticals Otsuka Filed Application in Japan for Approval of Fremanezumab as a Prophylactic Treatment for Migraine
8 JUL 2020 Pharmaceuticals Otsuka announces simultaneous regulatory approvals by U.S. FDA and Health Canada of INQOVI®, an oral hypomethylating agent (HMA) therapy for MDS and CMML
29 JUN 2020 Pharmaceuticals Novartis Pharma obtains manufacturing and marketing approval in Japan for Entresto® tablet as angiotensin receptor neprilysin inhibitor (ARNI) for chronic heart failure
29 JUN 2020 Pharmaceuticals Samsca®approved in Japan for additional indication of hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion (SIADH)
29 JUN 2020 Pharmaceuticals Otsuka Pharmaceutical and Axcelead Drug Discovery Partners announce joint research in CNS indications
24 JUN 2020 Pharmaceuticals Clinical program for NY-ESO-1/siTCRTM gene therapy candidate receives designation in Japan as Orphan Regenerative Medicine
19 JUN 2020 Pharmaceuticals Japan's MHLW grants Sakigake Designation to comprehensive genomic profiling assay for hematologic malignancies co-developed by Otsuka
16 JUN 2020 Nutraceuticals Introduction of Set of Heat Disorder-related Teaching Materials: "Get Back That Sweat! Preventing Heat Disorders Together"
16 JUN 2020 Pharmaceuticals Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma and Ocular Hypertension, AILAMIDE® Combination Ophthalmic Suspension
12 JUN 2020 Pharmaceuticals Otsuka Announces Positive Top-line Results from Two Phase 3 Studies of Centanafadine for the Treatment of Attention-deficit Hyperactivity Disorder (ADHD) in Adult Patients
25 MAY 2020 Pharmaceuticals Deltyba® (delamanid) approved in Russian Federation for treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB)
22 MAY 2020 Pharmaceuticals Launch of Aspirin/Vonoprazan Fumarate Combination Tablets: "Cabpirin® Combination Tablets"
5 MAY 2020 Pharmaceuticals Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
27 APR 2020 Corporate Otsuka Pharmaceutical to use CO2-free electricity at all plants in Japan (PDF: 96.4 KB)
24 APR 2020 Nutraceuticals Research on the Relationship Between Hair Problems and Capacity to Produce Equol
20 APR 2020 Pharmaceuticals Otsuka Enters into Licensing Agreement in Japan for Bempedoic Acid, a Treatment for Hypercholesterolemia
1 APR 2020 Pharmaceuticals Otsuka to Introduce QuickNaviTM-Adeno2, an Adenovirus Quick Measurement Kit- Faster and clearer test results with two contrasting colors -
26 MAR 2020 Pharmaceuticals Development of the first comprehensive genomic profiling assay for hematologic malignancies in Japan- Consortium of major Japanese hospitals and Otsuka Pharmaceutical start a project to evaluate its clinical utility -
26 MAR 2020 Pharmaceuticals Otsuka Announces Top-line Results from Two Phase 3 Studies in Japan for Atopic Dermatitis Drug Candidate Difamilast (OPA-15406)
25 MAR 2020 Pharmaceuticals Otsuka's Busulfex Receives Additional Indication in Japan as a Conditioning regimen Prior to Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoma
25 MAR 2020 Pharmaceuticals Cabpirin® Combination Tablet Receives Regulatory Approval in Japan for Treatment of Acid-related Diseases in Patients Needing Low-dose Aspirin
16 MAR 2020 Nutraceuticals Dietary Education App "SketchCook" Recognized with Ministry of Education, Culture, Sports, Science and Technology(MEXT) "Award for Companies Promoting Experience-based Learning Activities for Youth 2019"
13 MAR 2020 Nutraceuticals Newly published findings on inhibitory effect of near-infrared (IRA) radiation on human epidermal cell proliferation and potential mechanisms
10 MAR 2020 Corporate Otsuka Pharmaceutical Reappointments and New Appointments of Board Members and Statutory Auditors (PDF: 57.4 KB)
3 MAR 2020 Nutraceuticals Introducing InnerSignal Rejuvenate ONE-All-in-One Skin Care Product with Time-Lapse Penetration Combines Lightening and Three Basic Skin Care Functions-
2 MAR 2020 Pharmaceuticals Otsuka enters into co-promotion agreement for angiotensin receptor neprilysin inhibitor (ARNI) LCZ696 in Japan
27 FEB 2020 Pharmaceuticals First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
27 FEB 2020 Nutraceuticals Introducing New UL·OS Face & Body Sheet A single sheet provides convenient facial and body care
26 FEB 2020 Nutraceuticals Launch of "Health Support Plus" Service to manage workforce health based on desknet's NEO groupware
25 FEB 2020 Nutraceuticals Whole soy nutrition bar delivers the same satisfying crunchy texture with a significant reduction in sugars SOYJOY Peanuts Renewal Launch
14 FEB 2020 Pharmaceuticals Otsuka Pharmaceutical and the Japan Kidney Association Form Collaborative Agreement -Aim to identify practical uses of basic research in the kidney field-
12 FEB 2020 Pharmaceuticals Otsuka announces that subsidiary Astex Pharmaceuticals' NDA for ASTX727 (oral C-DEC), for the treatment of MDS and CMML, has been accepted for priority review by the U.S. FDA
6 FEB 2020 Nutraceuticals Tokyo Marathon 2020 - Connecting With the World Otsuka Pharmaceutical to be an Official Partner for 14th consecutive year
27 JAN 2020 Pharmaceuticals Otsuka announces positive top-line results from clinical trials in Japan offremanezumab as a prophylactic treatment for migraine
24 JAN 2020 Corporate Otsuka Pharmaceutical Awarded Grand Prize in Tokyo Metropolitan Government Women's Participation Awards for First Year of the Reiwa Era
21 JAN 2020 Pharmaceuticals Otsuka enters multi-project drug discovery collaboration with PhoreMost Limited